BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2449680)

  • 1. Immunohistochemical characterization of 130 cases of primary hepatic carcinomas.
    Ferrandez-Izquierdo A; Llombart-Bosch A
    Pathol Res Pract; 1987 Dec; 182(6):783-91. PubMed ID: 2449680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical study of the appearance of some markers in liver adjoining hepatocellular carcinoma.
    Cantaboni A; Sironi M; Taccagni GL; Ferrari AM
    Basic Appl Histochem; 1986; 30(2):165-72. PubMed ID: 2427060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of five antigens in hepatocellular carcinoma.
    Thung SN; Gerber MA; Sarno E; Popper H
    Lab Invest; 1979 Aug; 41(2):101-5. PubMed ID: 88543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunohistochemical study on HBsAg, HBcAg and AFP in 104 patients with small liver cancer].
    Zhang SP
    Zhonghua Zhong Liu Za Zhi; 1988 Sep; 10(5):353-6. PubMed ID: 2470564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunocytochemical evaluation of liver fine-needle aspirations.
    Bedrossian CW; Davila RM; Merenda G
    Arch Pathol Lab Med; 1989 Nov; 113(11):1225-30. PubMed ID: 2479356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemistry of hepatocellular carcinoma associated with cirrhosis.
    Espinoza CG; Pillarisetti SG; Azar HA
    Ann Clin Lab Sci; 1984; 14(6):467-73. PubMed ID: 6210034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of alpha-fetoprotein and immunoreactive carcinoembryonic antigen in human hepatocellular carcinoma and hepatoblastoma.
    Hirohashi S; Shimosato Y; Ino Y; Kishi K; Ohkura H; Mukojima T
    Jpn J Clin Oncol; 1983 Mar; 13(1):37-43. PubMed ID: 6187946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocellular carcinoma in Israel: relationship to hepatitis B virus infection.
    Yahalom J; Livni N; Fuks Z; Levij IS
    Isr J Med Sci; 1985 Jan; 21(1):1-5. PubMed ID: 2579047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters.
    Koelma IA; Nap M; Huitema S; Krom RA; Houthoff HJ
    Arch Pathol Lab Med; 1986 Nov; 110(11):1035-40. PubMed ID: 2430547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.
    Murugavel KG; Mathews S; Jayanthi V; Shankar EM; Hari R; Surendran R; Vengatesan A; Raghuram K; Rajasambandam P; Murali A; Srinivas U; Palaniswamy KR; Pugazhendhi T; Thyagarajan SP
    Int J Infect Dis; 2008 Nov; 12(6):e71-6. PubMed ID: 18658001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic characterization of hepatic proliferation. Antigenic expression by proliferating epithelial cells in fetal liver, massive hepatic necrosis, and nodular transformation of the liver.
    Gerber MA; Thung SN; Shen S; Stromeyer FW; Ishak KG
    Am J Pathol; 1983 Jan; 110(1):70-4. PubMed ID: 6185004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B virus surface and core antigens in the liver of primary hepatocellular carcinoma cases in Virginia.
    Swenson PD; Escobar MR; Silverman JF
    Acta Biol Acad Sci Hung; 1980; 31(1-3):321-8. PubMed ID: 6261496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocellular dysplasia: immunohistochemical and morphometrical evaluation.
    Pollice L; Ricco R; Russo S; Maiorano E; Pagniello G; Delfino-Pesce V
    Appl Pathol; 1988; 6(2):73-81. PubMed ID: 2455530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
    Lau SK; Prakash S; Geller SA; Alsabeh R
    Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic markers of hepatocellular carcinoma.
    Chedid A; Chejfec G; Eichorst M; Villamil F; Terg R; Telenta M; Hojman R
    Cancer; 1990 Jan; 65(1):84-7. PubMed ID: 1688400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
    Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
    Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical study on hepatic tumors--KM01 stains compared with AFP, CEA, CA19-9 and RAS P21.
    Hanabata M; Ohyanagi H; Saitoh Y; Itoh H
    Kobe J Med Sci; 1991 Apr; 37(2):81-96. PubMed ID: 1717740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic markers in primary and metastatic tumors of the liver.
    Ganjei P; Nadji M; Albores-Saavedra J; Morales AR
    Cancer; 1988 Nov; 62(9):1994-8. PubMed ID: 2458825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.
    Röcken C; Licht J; Roessner A; Carl-McGrath S
    J Clin Pathol; 2005 Oct; 58(10):1069-75. PubMed ID: 16189153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver cell dysplasia in alpha-1-antitrypsin deficiency.
    Cohen C; Derose PB
    Mod Pathol; 1994 Jan; 7(1):31-6. PubMed ID: 8159650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.